SNDX FY 2020 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

SNDXSyndax Pharmaceuticals, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+0.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$71M-4708.2% margin

Net Income

-$73M-4816.7% margin

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$71M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$301M

Total Liabilities

$48M

Stockholders' Equity

$252M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+0.0%
Gross Profit	$2M	$2M	+0.0%
Operating Income	-$71M	-$58M	-24.1%
Net Income	-$73M	-$56M	-30.6%